Daniel J. Wallace, MD
Opted out of Medicare from March 2024 to March 2028. Internal Medicine, Rheumatology (MD) in Beverly Hills, California, licensed in CA, with an NPI issued in June 2005. Their prescriptions cost Medicare Part D more than their services did: $1,202,732 for 1,615 claims, against $77,416 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 10 companies reporting payments in 2025, $50,550 in all, mostly speaking and faculty fees.
Overview
| NPI | 1982608717 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Jun 9, 2005 |
| Last updated in NPPES | Oct 20, 2026 |
| Certified by provider | Mar 10, 2022 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Rheumatology Primary | 207RR0500X | G30533 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Mar 27, 2024 – Mar 27, 2028 |
| Can order and refer | Yes |
| Accepts assignment | Yes (participating) |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Medicare services in 2024
| Medicare patients | 62 |
|---|---|
| Services billed | 7,050 across 27 procedure codes |
| Paid by Medicare | $77,416 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,615 · 2,659 30-day fills |
|---|---|
| Patients | 244 |
| Total drug cost | $1,202,732 |
| Generic share | 84% of claims |
Industry payments (Open Payments)
- 2025$50,550 · 68 payments from 10 companies
- 2024$16,833 · 114 payments from 17 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $37,884 | 24 |
| Glaxosmithkline, LLC. | $4,225 | 5 |
| Astrazeneca Uk Limited | $3,783 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,988 | 2 |
| Merck Kgaa | $1,880 | 1 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$29,970 · 13 payments
- Travel and Lodging$12,103 · 5 payments
- Consulting Fee$6,948 · 3 payments
- Food and Beverage$1,529 · 47 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Rheumatology providers in Beverly Hills
- 1174692131
- 1093626525
- 1689864332
- 1699793570
- 1679652507
- 1639256894
- 1871749606
- 1679479232
- 1407857964
- 1912280090
- 1013941343
- 1962602375
All Internal Medicine, Rheumatology providers in California →